Clinical Characteristics, Socio-Demographic Profile, and Quality of Life among Children With Thalassemia Major: A Hospital Based Cross-Sectional Study
DOI:
https://doi.org/10.47203/IJCH.2026.v38i05.005Keywords:
Thalassemia, Paediatric quality of life, PedsQL, Transfusion frequency, HRQoLAbstract
Background: Thalassemia major imposes a multi-dimensional burden on the health-related quality of life (HRQoL) of affected children. The Paediatric Quality of Life Inventory (PedsQL) provides a validated, multidimensional assessment of functioning in physical, social, emotional, and school domains. Region-specific data from North India on children's QoL and its clinical determinants remain limited. Material & Methods: A cross-sectional study was conducted among 100 children with thalassemia major (aged 2–18 years) attending a Blood Transfusion Centre in a tertiary care centre of Haryana. Data related to Socio-demographic and clinical profile were recorded. PedsQL 4.0 Generic Core Scales was used for assessment of QoL. Independent samples t-test and Kruskal Wallis Test were applied for assessing associations (p <0.05). Results: The mean PedsQL score was 84.47 ± 8.16. Female children had significantly lower (worse) mean QoL scores than males (81.32 ± 9.85 vs 86.84 ± 5.61, p < 0.001). Children requiring high-frequency transfusions had significantly lower mean QoL scores than those with low-frequency transfusions (83.00 ± 8.63 vs. 88.24 ± 5.26; p = 0.003). Religion, residence, and education were not significantly associated with QoL. Conclusion: A substantial proportion of children with thalassemia have compromised QoL. Female gender and higher transfusion frequency are significant determinants of poorer HRQoL. Gender-sensitive psychosocial support and strategies to reduce transfusion burden are critical components of holistic paediatric thalassemia care.
Downloads
References
1. Yadav PK, Singh AK. A review of iron overload in beta-thalassemia major, and a discussion on alternative potent iron chelation targets. Plasmatology. 2022 May;16: 26348535221103560.
2. Malakar R, Kour M, Malviya SN, Dangi CB. A review on β-thalassemia. World J Pharm Res. 2016 Mar 28;5(6): 432-45.
3. Chinnaiyan S, Sylvia J, Kothandaraman S, Palanisamy B. Quality of life and thalassemia in India: A scoping review. J Family Med Prim Care. 2024 Apr;13(4): 1183-90.
4. Ababneh S, Siyam AAA, Alzoubi MM, Al-Sawalha NA, Al Sukhni FF, Al Rahbeni T, et al. Assessment of health-related quality of life in transfusion dependent beta thalassemia. Sci Rep. 2025 Sep 2;15(1): 32267.
5. Shah R, Badawy SM. Health-related quality of life with standard and curative therapies in thalassemia: a narrative literature review. Ann N Y Acad Sci. 2024 Feb;1532(1): 50-62.
6. Desai AD, Zhou C, Stanford S, Haaland W, Varni JW, Mangione-Smith RM. Validity and responsiveness of the Pediatric Quality of Life Inventory (PedsQL) 4.0 generic core scales in the pediatric inpatient setting. JAMA Pediatr. 2014 Dec;168(12): 1114-21.
7. Hossain MJ, Islam MW, Munni UR, Gulshan R, Mukta SA, Miah MS, et al. Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire. Sci Rep. 2023;13:7734.
8. Greco F, Marino F. Social impact and quality of life of patients with β-thalassaemia: a systematic review. EMJ Hematol. 2022; 40-52.
9. Jajhara I, Choudhary G, Singh J, Chachan V, Kumar A. A Study on Quality of life among thalassemic children aged 8 to 18 years. Int J Contemp Pediatr. 2021;8(10): 1667-74.
10. Nadgir A, Wajapey P, Samaja YSS, Ramya SK. Health-related quality of life in children aged 8-12 years with thalassemia: a cross-sectional study using the pediatric quality of life inventory PedsQL. Int J Res Med Sci 2026;14: 1046-50.
11. Mansoor S, Othman Z, Othman A, Husain M. Quality of life among adolescents with beta-thalassemia major in the Maldives. Int Med J. 2018;25(4): 211-14.
12. Drahos J, Boateng-Kuffour A, Calvert M, Levine L, Dongha N, Li N, et al. Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment. Patient. 2024 Jul;17(4): 421-39.
13. Cappellini MD, Taher AT, Piga A, Shah F, Voskaridou E, Viprakasit V, et al. Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept. Eur J Haematol. 2023 Jul;111(1): 113-24.
14. Chordiya K, Katewa V, Sharma P, Deopa B, Katewa S. Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children. Indian J Pediatr. 2018 Nov;85(11): 978-83.
15. Alshamsi S, Hamidi S, Narci HO. Health-related quality of life and associated factors of children with transfusion-dependent thalassemia in Dubai, United Arab Emirates. Glob J Health Sci. 2021;13(7): 18-31.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Saroj Kartik Ankit Choudhury, Kashish Grover, Rohit Katre, Pallavi Singh, Vaishali, Anshu Mittal (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
